Wednesday, April 3, 2013

British Journal of Cancer - Table of Contents alert Volume 108 Issue 6


TABLE OF CONTENTS

Volume 108, Issue 6 (1225-1392)
Published online 2 April 2013

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Letters to the Editor

Also new today
Advance online publication

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Minireview

Top

Proton beam therapy and localised prostate cancer: current status and controversies

J A Efstathiou, P J Gray and A L Zietman

Br J Cancer 2013 108: 1225-1230; advance online publication, March 12, 2013; 10.1038/bjc.2013.100

Abstract | Full Text

Clinical Studies

Top

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study

J L Lesnock, K M Darcy, C Tian, J A DeLoia, M M Thrall, C Zahn, D K Armstrong, M J Birrer and T C Krivak

Br J Cancer 2013 108: 1231-1237; advance online publication, March 5, 2013; 10.1038/bjc.2013.70

Abstract | Full Text

ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy

P Li, Y J Fang, F Li, Q J Ou, G Chen and G Ma

Br J Cancer 2013 108: 1238-1244; advance online publication, March 12, 2013; 10.1038/bjc.2013.83

Abstract | Full Text

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

Y-K Kang, H-M Chang, J H Yook, M-H Ryu, I Park, Y J Min, D Y Zang, G Y Kim, D H Yang, S J Jang, Y S Park, J-L Lee, T W Kim, S T Oh, B K Park, H-Y Jung and B S Kim

Br J Cancer 2013 108: 1245-1251; advance online publication, February 28, 2013; 10.1038/bjc.2013.86

Abstract | Full Text

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

T Meyer, A Kirkwood, M Roughton, S Beare, E Tsochatzis, D Yu, N Davies, E Williams, S P Pereira, D Hochhauser, A Mayer, R Gillmore, J O'Beirne, D Patch and A K Burroughs

Br J Cancer 2013 108: 1252-1259; advance online publication, February 28, 2013; 10.1038/bjc.2013.85

Abstract | Full Text

Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma

K Yoshimura, T Minami, M Nozawa and H Uemura

Br J Cancer 2013 108: 1260-1266; advance online publication, March 7, 2013; 10.1038/bjc.2013.90

Abstract | Full Text

Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer

M Koskas, E Chereau, M Ballester, G Dubernard, F Lécuru, D Heitz, P Mathevet, H Marret, D Querleu, F Golfier, E Leblanc, D Luton, R Rouzier and E Daraï

Br J Cancer 2013 108: 1267-1272; advance online publication, March 12, 2013; 10.1038/bjc.2013.95

Abstract | Full Text

Does referral to specialist paediatric palliative care services reduce hospital admissions in oncology patients at the end of life?

L K Fraser, M van Laar, M Miller, J Aldridge, P A McKinney, R C Parslow and R G Feltbower

Br J Cancer 2013 108: 1273-1279; advance online publication, February 28, 2013; 10.1038/bjc.2013.89

Abstract | Full Text

Childhood cancer and factors related to prolonged diagnostic intervals: a Danish population-based study

J M Ahrensberg, F Olesen, R P Hansen, H Schrøder and P Vedsted

Br J Cancer 2013 108: 1280-1287; advance online publication, February 28, 2013; 10.1038/bjc.2013.88

Abstract | Full Text

Translational Therapeutics

Top

Using macrophage activation to augment immunotherapy of established tumours

Z G Fridlender, A Jassar, I Mishalian, L-CS Wang, V Kapoor, G Cheng, J Sun, S Singhal, L Levy and S M Albelda

Br J Cancer 2013 108: 1288-1297; advance online publication, March 12, 2013; 10.1038/bjc.2013.93

Abstract | Full Text

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours

M Quintela-Fandino, M Krzyzanowska, G Duncan, A Young, M J Moore, E X Chen, A Stathis, R Colomer, J Petronis, M Grewal, S Webster, L Wang and L L Siu

Br J Cancer 2013 108: 1298-1305; advance online publication, February 14, 2013; 10.1038/bjc.2013.64

Abstract | Full Text

Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

S M Tijono, K Guo, K Henare, B D Palmer, L-C S Wang, S M Albelda and L-M Ching

Br J Cancer 2013 108: 1306-1315; advance online publication, March 12, 2013; 10.1038/bjc.2013.101

Abstract | Full Text

Molecular Diagnostics

Top

Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

J M Jürgensmeier, H-J Schmoll, J D Robertson, L Brooks, M Taboada, S R Morgan, D Wilson and P M Hoff

Br J Cancer 2013 108: 1316-1323; advance online publication, February 28, 2013; 10.1038/bjc.2013.79

Abstract | Full Text

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma

Y Nishimura, S Komatsu, D Ichikawa, H Nagata, S Hirajima, H Takeshita, T Kawaguchi, T Arita, H Konishi, K Kashimoto, A Shiozaki, H Fujiwara, K Okamoto, H Tsuda and E Otsuji

Br J Cancer 2013 108: 1324-1331; advance online publication, February 19, 2013; 10.1038/bjc.2013.65

Abstract | Full Text

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma

A G Schache, T Liloglou, J M Risk, T M Jones, X-J Ma, H Wang, S Bui, Y Luo, P Sloan, R J Shaw and M Robinson

Br J Cancer 2013 108: 1332-1339; advance online publication, February 14, 2013; 10.1038/bjc.2013.63

Abstract | Full Text

The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma

L E Dalton, H J Clarke, J Knight, M H Lawson, J Wason, D A Lomas, W J Howat, R C Rintoul, D M Rassl and S J Marciniak

Br J Cancer 2013 108: 1340-1347; advance online publication, February 14, 2013; 10.1038/bjc.2013.66

Abstract | Full Text

Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer

K Matsuo, S Mabuchi, M Okazawa, Y Matsumoto, T Tsutsui, M Fujita, S Kamiura, K Ogawa, C P Morrow and T Kimura

Br J Cancer 2013 108: 1348-1357; advance online publication, March 5, 2013; 10.1038/bjc.2013.78

Abstract | Full Text

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

D J E Peeters, B De Laere, G G Van den Eynden, S J Van Laere, F Rothé, M Ignatiadis, A M Sieuwerts, D Lambrechts, A Rutten, P A van Dam, P Pauwels, M Peeters, P B Vermeulen and L Y Dirix

Br J Cancer 2013 108: 1358-1367; advance online publication, March 7, 2013; 10.1038/bjc.2013.92

Abstract | Full Text

Genetics & Genomics

Top

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer

L E De Faveri, C D Hurst, F M Platt, C F Taylor, J-A Roulson, M Sanchez-Carbayo, M A Knowles and E J Chapman

Br J Cancer 2013 108: 1368-1377; 10.1038/bjc.2013.104

Abstract | Full Text

Common genetic variants in the 9p21 region and their associations with multiple tumours

F Gu, R M Pfeiffer, S Bhattacharjee, S S Han, P R Taylor, S Berndt, H Yang, A J Sigurdson, J Toro, L Mirabello, M H Greene, N D Freedman, C C Abnet, S M Dawsey, N Hu, Y-L Qiao, T Ding, A V Brenner, M Garcia-Closas, R Hayes, L A Brinton, J Lissowska, N Wentzensen, C Kratz, L E Moore, R G Ziegler, W-H Chow, S A Savage, L Burdette, M Yeager, S J Chanock, N Chatterjee, M A Tucker, A M Goldstein and X R Yang

Br J Cancer 2013 108: 1378-1386; advance online publication, January 29, 2013; 10.1038/bjc.2013.7

Abstract | Full Text

Letters to the Editor

Top

On the clinical relevance of circulating endothelial cells and platelets in prostate cancer

F Bertolini, Y Shaked and P Mancuso

Br J Cancer 2013 108: 1387; advance online publication, February 14, 2013; 10.1038/bjc.2012.528

Full Text

Reply: On the clinical relevance of circulating endothelial cells and platelets in prostate cancer

C K E Wong, B Namdarian, J Chua, X Chin, R Speirs, T Nguyen, M Fankhauser, J Pedersen, A J Costello, N M Corcoran and C M Hovens

Br J Cancer 2013 108: 1388; advance online publication, February 14, 2013; 10.1038/bjc.2012.529

Full Text

False positive result in study on hookah smoking and cancer in Kashmir: measuring risk of poor hygiene is not the same as measuring risk of inhaling water filtered tobacco smoke all over the world

K Chaouachi

Br J Cancer 2013 108: 1389-1390; advance online publication, March 7, 2013; 10.1038/bjc.2013.98

Full Text

Reply: False positive result in study on hookah smoking and cancer in Kashmir: measuring risk of poor hygiene is not the same as measuring risk of inhaling water-filtered tobacco smoke all over the world

N A Dar, F Islami and P Boffetta

Br J Cancer 2013 108: 1391-1392; advance online publication, March 7, 2013; 10.1038/bjc.2013.99

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: